San Diego biotech lays off nearly all its staff after drug trial failure and 2 patient deaths
San Diego biotech Artiva Biotherapeutics is laying off about 94% of its workforce and abandoning its lead immunotherapy treatment for rheumatoid arthritis roughly five months after raising about $300 million from investors. The company said Tuesday that updated data showed its lead…